ArticleEClinicalMedicine2026

Weight loss and cardiovascular outcomes with incretin-based therapies after metabolic and bariatric surgery: a nationwide US cohort study.

Andrew Gillikin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.